Fitt Insider Oura's Acquisition, Amazon's AI Healthcare Agent, Longevity's $8 Trillion Rise
Mar 6, 2026
A fast look at Amazon's new AI tool that automates healthcare admin and cuts abandoned calls. UBS predicts longevity spending could reach $8 trillion by 2030, driven by GLP-1 drugs and new prevention markets. Oura buys Doublepoint to add biometric gesture controls and push a "cloud of wearables" vision.
AI Snips
Chapters
Transcript
Episode notes
AWS Is Using AI To Frontload Healthcare Admin
- Amazon Web Services launched Amazon Connect Health to automate administrative healthcare tasks like scheduling, patient verification, documentation, and billing integrated with EHRs.
- Early deployments (e.g., UC San Diego Health) saved ~1 minute per call and cut abandoned calls by up to 30%, freeing staff for care.
Longevity Spending Could Become An $8 Trillion Market
- UBS projects global longevity-related spending will hit $8 trillion annually by 2030 across biotech, diagnostics, supplements, fitness, and wellness real estate.
- UBS expects GLP-1 drugs alone could surpass $200 billion in annual sales this decade as aging populations and preventative care expand markets.
Oura Bought Gesture Tech To Power A Cloud Of Wearables
- Oura acquired Finnish startup DoublePoint to add biometric gesture controls enabling subtle hand-movement interaction with devices instead of screens.
- The move supports Oura's vision of a "cloud of wearables" where multiple sensors feed a central analytics layer and ring acts as interface.